See more : Black Tusk Resources Inc. (TUSK.CN) Income Statement Analysis – Financial Results
Complete financial analysis of FINDEX Inc. (3649.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of FINDEX Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Balrampur Chini Mills Limited (BALRAMCHIN.BO) Income Statement Analysis – Financial Results
- Worth Peripherals Limited (WORTH.NS) Income Statement Analysis – Financial Results
- Acepodia, Inc. (6976.TWO) Income Statement Analysis – Financial Results
- d’Amico International Shipping S.A. (DMCOF) Income Statement Analysis – Financial Results
- BTC Digital Ltd. (BTCT) Income Statement Analysis – Financial Results
FINDEX Inc. (3649.T)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.findex.co.jp
About FINDEX Inc.
FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 5.19B | 4.54B | 4.97B | 4.00B | 4.28B | 3.60B | 3.31B | 3.29B | 2.95B | 2.86B | 2.38B | 1.99B | 1.54B | 1.14B | 772.03M |
Cost of Revenue | 1.86B | 1.82B | 2.41B | 1.89B | 1.95B | 1.61B | 1.42B | 1.33B | 1.31B | 1.08B | 949.47M | 772.35M | 701.15M | 442.21M | 331.41M |
Gross Profit | 3.33B | 2.72B | 2.56B | 2.12B | 2.33B | 1.99B | 1.89B | 1.95B | 1.64B | 1.78B | 1.43B | 1.22B | 842.01M | 702.56M | 440.63M |
Gross Profit Ratio | 64.13% | 59.96% | 51.45% | 52.93% | 54.43% | 55.33% | 57.20% | 59.41% | 55.62% | 62.17% | 60.15% | 61.15% | 54.56% | 61.37% | 57.07% |
Research & Development | 52.00M | 39.02M | 27.07M | 43.32M | 23.42M | 37.58M | 13.48M | 6.04M | 2.97M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.78B | 1.66B | 1.61B | 1.41B | 1.51B | 1.31B | 1.33B | 1.15B | 924.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 0.00 | 1.69B | 1.64B | 1.48B | 1.59B | 1.20M | 914.00K | 511.00K | 535.00K | 15.79M | 23.59M | 27.26M | -114.00K | -1.75M | -1.24M |
Operating Expenses | 1.83B | 1.69B | 1.64B | 1.48B | 1.59B | 1.40B | 1.35B | 1.23B | 971.66M | 787.79M | 618.40M | 505.12M | 439.27M | 366.22M | 290.74M |
Cost & Expenses | 3.70B | 3.51B | 4.05B | 3.37B | 3.54B | 3.01B | 2.77B | 2.56B | 2.28B | 1.87B | 1.57B | 1.28B | 1.14B | 808.43M | 622.15M |
Interest Income | 72.00K | 47.00K | 22.00K | 31.00K | 25.00K | 30.00K | 29.00K | 136.00K | 568.00K | 229.00K | 166.00K | 397.00K | 82.00K | 142.00K | 75.00K |
Interest Expense | 0.00 | 448.00K | 2.00K | 0.00 | 0.00 | 323.00K | 80.00K | 240.00K | 160.00K | 160.00K | 160.00K | 744.00K | 1.43M | 4.09M | 4.88M |
Depreciation & Amortization | 257.75M | 254.96M | 308.30M | 380.98M | 425.83M | 407.05M | 377.56M | 348.71M | 306.13M | 286.04M | 241.34M | 179.36M | 123.87M | 86.27M | 69.28M |
EBITDA | 1.78B | 1.32B | 1.25B | 1.03B | 1.17B | 1.00B | 925.18M | 1.07B | 975.36M | 1.28B | 1.08B | 915.05M | 518.27M | 420.99M | 219.11M |
EBITDA Ratio | 34.33% | 28.87% | 25.21% | 25.38% | 27.36% | 27.75% | 27.89% | 32.64% | 33.15% | 44.65% | 44.33% | 46.10% | 33.72% | 36.78% | 28.06% |
Operating Income | 1.50B | 1.03B | 920.72M | 636.28M | 743.01M | 592.97M | 546.50M | 724.66M | 670.29M | 992.76M | 814.77M | 710.32M | 402.74M | 336.34M | 149.89M |
Operating Income Ratio | 28.83% | 22.65% | 18.53% | 15.89% | 17.35% | 16.46% | 16.50% | 22.04% | 22.71% | 34.66% | 34.20% | 35.73% | 26.10% | 29.38% | 19.41% |
Total Other Income/Expenses | 27.88M | 31.93M | 23.87M | 8.08M | 917.00K | 904.00K | 1.38M | 157.00K | -1.06M | 15.86M | 23.60M | 24.62M | -9.77M | -5.71M | -6.36M |
Income Before Tax | 1.52B | 1.06B | 944.59M | 644.36M | 743.93M | 593.88M | 547.62M | 724.82M | 669.23M | 1.01B | 838.37M | 734.95M | 392.97M | 330.63M | 143.53M |
Income Before Tax Ratio | 29.36% | 23.35% | 19.01% | 16.09% | 17.38% | 16.48% | 16.54% | 22.04% | 22.67% | 35.22% | 35.19% | 36.97% | 25.47% | 28.88% | 18.59% |
Income Tax Expense | 463.02M | 336.21M | 308.80M | 213.90M | 244.68M | 195.86M | 185.39M | 224.91M | 227.83M | 378.55M | 320.53M | 303.07M | 171.01M | 137.54M | 58.64M |
Net Income | 1.06B | 722.78M | 636.03M | 430.46M | 499.25M | 398.02M | 366.63M | 499.92M | 441.40M | 630.07M | 517.84M | 431.88M | 221.96M | 193.09M | 84.89M |
Net Income Ratio | 20.40% | 15.92% | 12.80% | 10.75% | 11.66% | 11.05% | 11.07% | 15.20% | 14.95% | 22.00% | 21.73% | 21.73% | 14.38% | 16.87% | 11.00% |
EPS | 41.31 | 28.21 | 24.84 | 16.81 | 19.50 | 15.43 | 14.21 | 19.35 | 17.00 | 24.25 | 19.95 | 16.87 | 9.33 | 9.82 | 433.49 |
EPS Diluted | 41.31 | 28.21 | 24.84 | 16.81 | 19.50 | 15.30 | 13.96 | 18.97 | 16.61 | 23.69 | 19.47 | 16.24 | 8.86 | 9.82 | 433.49 |
Weighted Avg Shares Out | 25.64M | 25.62M | 25.61M | 25.60M | 25.60M | 25.80M | 25.79M | 25.83M | 25.96M | 25.98M | 25.96M | 25.60M | 23.79M | 19.67M | 195.84K |
Weighted Avg Shares Out (Dil) | 25.64M | 25.62M | 25.61M | 25.60M | 25.60M | 26.01M | 26.26M | 26.35M | 26.57M | 26.60M | 26.60M | 26.59M | 25.05M | 19.67M | 195.84K |
Source: https://incomestatements.info
Category: Stock Reports